Bristol Myers Squibb and RayzeBio, Inc., announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in...
Tigera, provider of the industry's only active security platform for containers and Kubernetes, announced key achievements from 2023 and continued momentum as it looks...
Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune...
IMCD N.V., a global leading distribution partner, and formulator of speciality chemicals and ingredients, announces that IMCD Colombia has signed an agreement to acquire...
